Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccine with PCV13 or PPV23 in Elderly
NCT02582047Phase 4Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Oct 2012
- Primary completion
- Dec 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of GC Flu Quadrivalent in influenza, pneumococcal infection, sponsored by Korea University Guro Hospital. Started Oct 2012; status: completed.
02
Drugs
GC Flu Quadrivalent
03
Conditions
influenzapneumococcal infection
Beyond the preview
Go deeper on NCT02582047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02582047.